Nuo Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Nuo Therapeutics Inc inventory turnover ratio, the Nuo Therapeutics Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 6.42 in the first quarter 2026, yet the ratio remained below the average, as NUOT's market remain challenging.Average inventory processing period, for the Nuo Therapeutics Inc in Mar 31 2026 quarter, has decreased to 57 days, compare to 62 days, in the Dec 31 2025 quarter.

Within Healthcare sector 61 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 544, from total ranking in the fourth quarter 2025 at 673.

NUOT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Nuo Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NUOT Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	150.61 %	42.09 %	20.18 %	-23.52 %	-53.08 %
Y / Y Cost of Sales Growth	273.81 %	262.11 %	304.68 %	143.9 %	139.21 %
Inventory Turnover Ratio (TTM)	6.42	5.88	5.01	3.2	2.35
NUOT's Total Ranking	# 544	# 673	# 673	# 1011	# 1701
Average inventory processing period	57	62	73	114	155
Seq. Inventory Growth	16.27 %	6.02 %	21.6 %	67.2 %	-34.08 %
Seq. Cost of Sales Growth	44.58 %	-23.07 %	155.24 %	31.67 %	40.05 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 23
Healthcare Sector	# 62
Overall Market	# 544

Inventory Turnover Ratio Statistics
High	Average	Low
114.14	17.32	0.09
(Mar 31 2017)		(Dec 31 2022)

NUOT Company Profile >> Back to NUOT Efficiency Comparisons >> Compare NUOT Inventory Turnover Ratio to its Competitors

Financial Statements
Nuo Therapeutics Inc 's Inventories	$ 0 Millions	Visit NUOT's Balance sheet
Nuo Therapeutics Inc 's Cost of Revenues TTM	$ 1 Millions	Visit NUOT's Income Statement
What are NUOT's Sales?		Visit NUOT's Sales by Segment

Other Inventory Turnover Ratios
Nuo Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NUOT's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NUOT's Competitors
Inventory Turnover Ratio for NUOT's Suppliers
Inventory Turnover Ratio for NUOT's Customers

You may also want to know
NUOT's Sales Growth Rates	NUOT's Pe Price to earnings ratio	NUOT's Receivables Turnover Ratio	NUOT's Stock Quote
NUOT's Net Income Growth Rates	NUOT's Ps Price to Sales ratio	NUOT's Sales per Employee	NUOT's Asset Turnover Ratio
NUOT's Net Margin	NUOT's Pb Price to Book ratio	NUOT's Financial Strength Ratios	NUOT's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Aurinia Pharmaceuticals Inc	14.12	$ 30.596 Millions	$ 2 Millions
Star Equity Holdings Inc	13.78	$ 106.877 Millions	$ 8 Millions
Natera Inc	13.48	$ 869.958 Millions	$ 65 Millions
Cryo cell International Inc	13.44	$ 7.049 Millions	$ 1 Millions
The Oncology Institute Inc	11.17	$ 211.805 Millions	$ 19 Millions
Genedx Holdings Corp	11.09	$ 135.000 Millions	$ 12 Millions
Infusystem Holdings Inc	10.96	$ 61.593 Millions	$ 6 Millions
Irhythm Holdings Inc	10.94	$ 228.000 Millions	$ 21 Millions
Earth Science Tech Inc	10.81	$ 8.224 Millions	$ 1 Millions
Option Care Health Inc	10.74	$ 4,579.720 Millions	$ 427 Millions
Zevra Therapeutics Inc	10.44	$ 17.034 Millions	$ 2 Millions
Alnylam Pharmaceuticals Inc	10.38	$ 814.503 Millions	$ 78 Millions
Nutriband Inc	10.06	$ 1.291 Millions	$ 0 Millions
Lantheus Holdings Inc	9.75	$ 610.000 Millions	$ 63 Millions
Sotera Health Company	9.58	$ 531.000 Millions	$ 55 Millions
Warby Parker Inc	9.23	$ 415.000 Millions	$ 45 Millions
Tarsus Pharmaceuticals Inc	9.09	$ 37.864 Millions	$ 4 Millions
National Vision Holdings Inc	8.90	$ 833.415 Millions	$ 94 Millions
Myriad Genetics Inc	8.35	$ 248.000 Millions	$ 30 Millions
Pulse Biosciences Inc	8.08	$ 0.909 Millions	$ 0 Millions
Castle Biosciences Inc	7.97	$ 75.178 Millions	$ 9 Millions
Moderna Inc	7.96	$ 1,733.000 Millions	$ 218 Millions
Carlsmed Inc	7.95	$ 12.557 Millions	$ 2 Millions
Inogen Inc	7.80	$ 195.741 Millions	$ 25 Millions
Cardiff Lexington Corporation	7.70	$ 4.159 Millions	$ 1 Millions
Novavax inc	7.67	$ 89.620 Millions	$ 12 Millions
Prophase Labs Inc	7.64	$ 2.361 Millions	$ 0 Millions
Bellevue Life Sciences Acquisition Corp	7.62	$ 1.986 Millions	$ 0 Millions
Lifemd Inc	7.60	$ 24.000 Millions	$ 3 Millions
Charles River Laboratories International inc	7.56	$ 2,346.239 Millions	$ 310 Millions

Date modified: 2026-09-08T15:11:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.